Live data from Hacker News

Nicotine patches as a possible treatment for long covid and me/cfs

bioelecmed.biomedcentral.com

1–10 of 12 posts

Re: Nicotine patches as a possible treatment for long covid and me/cfs

#3

Nicotine is highly addictive.

„In contrast to the well-known addictive potential linked to the chronic inhalation of nicotine, none of the trials could show a nicotine dependency after the withdrawal of transcutaneous nicotine application at the end of the investigations“

Re: Nicotine patches as a possible treatment for long covid and me/cfs

#4

Nicotine is highly addictive.

Which is why vaping helps people quit when you can dose modify your intake. https://www.cochrane.org/CD010216/TOBACCO_can-electronic-cig...

Nicotine is a fascinating topic. I do wonder if, in the context of massive obesity prevalent in America, society would be better off with nicotine addiction.

Could it be analogous to how caffeine addiction in our history kick started the knowledge work revolution?

Re: Nicotine patches as a possible treatment for long covid and me/cfs

#5

Nicotine is highly addictive.

Well, if the choice is between “[being] unable to proceed with common everyday activities due to weakness, memory lapses, pain, dyspnea and other unspecific physical complaints” and addicted to a substance that itself has mild side effects, I suspect many would choose the addiction.

Remember, nicotine!=tobacco

Re: Nicotine patches as a possible treatment for long covid and me/cfs

#6
post #5

Nicotine is highly addictive.

Well, if the choice is between “[being] unable to proceed with common everyday activities due to weakness, memory lapses, pain, dyspnea and other unspecific physical complaints” and addicted to a substance that itself has mild side effects, I suspect many would choose the addiction. Remember, nicotine!=tobacco

for some reason, people see addictive substances as extra bad if there are positive benefits to be had. nobody whinges as hard about a night out drinking though.

Re: Nicotine patches as a possible treatment for long covid and me/cfs

#10

A study with sample size of 4?

The study summary addresses this.

“The presentation of four individual case descriptions does not allow for general conclusions to be made about the therapeutic effect of transcutaneous nicotine administration in post-COVD-19 syndrome; this would require double-blinded, randomized studies. Due to the minimal therapeutic intervention, studies such as these have the potential to be carried out rather easily. Due to the lack of blinding, the author believes that the psychosomatic component, which other authors suspect to be a central component of long-haul COVID (Stengel et al. 2021), cannot be safely ruled out as part of the therapeutic effect. However, no symptom-related relapses were observed in a follow-up telephone consultation with the patients three to six months post-intervention.”

Post reply on HN